Terbinafine Topical Creams /Solutions bulk supplier for pharma manufacturers

Terbinafine Topical Creams /Solutions 1% cream, 1% solution Suppliers & Bulk Manufacturers

Available Forms: Topical Creams /Solutions

Available Strengths: 1% cream, 1% solution

Reference Brands: Lamisil(US & EU)

Terbinafine inhibits fungal squalene epoxidase, disrupting ergosterol synthesis and damaging fungal cell membranes. It effectively treats dermatophyte skin infections with rapid relief, broad antifungal activity, and minimal side effects. Topical formulations provide targeted therapy for skin infections, ensuring effective, localized treatment with safety and convenience.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Terbinafine topical creams and solutions are approved in the EU and US for treating dermatophyte skin infections. In the EU, brands like Lamisil are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA-approved terbinafine topical products, such as Lamisil, are backed by comprehensive clinical data and pharmacovigilance. Both regions require detailed dossiers for approval and continuous safety monitoring. For expert assistance with regulatory submissions, dossiers, and compliance, visit PharmaTradz. We support efficient market entry for terbinafine topical formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.

Terbinafine Topical Creams /Solutions — third party manufacturing & bulk supply

Terbinafine Topical Creams /Solutions 1% cream, 1% solution is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Terbinafine Topical Creams /Solutions is supplied as Topical Creams /Solutions — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Terbinafine Topical Creams /Solutions listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Terbinafine Topical Creams /Solutions →

Back to Listing

Frequently Asked Questions

Terbinafine is used to treat fungal infections of the skin, hair, and nails, such as athlete’s foot, ringworm, jock itch, and onychomycosis (nail fungus). It works by inhibiting the enzyme squalene epoxidase, which is essential for fungal cell membrane synthesis, leading to the death of the fungal cells.

Terbinafine is a synthetic allylamine antifungal compound chemically derived from naphthalene and allylamine structures. It is formulated as Terbinafine Hydrochloride in tablets, creams, gels, sprays, and oral granules.

Common trade names include Lamisil, Terbinex, and Zimig.

The original brand Lamisil was developed and marketed by Novartis. Several other pharmaceutical companies now produce generic versions worldwide, including Sun Pharma, Sandoz, and Teva.

The generic name is Terbinafine (usually in the form of Terbinafine Hydrochloride).

The brand names include Lamisil, Terbinex, and Zimig.

Terbinafine is manufactured globally by various pharmaceutical companies, including facilities in Switzerland, India, the USA, and the UK, under brands and generics by Novartis, Sandoz, and Sun Pharma.